CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 80 target
Drug / intervention
Cultivated conjunctival transplantationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00346450
NCT00346450Phase 3Completed
CompareCT.gov

Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface

Singapore National Eye Centre·interventional·Posted Jun 30, 2006·Updated Jan 13, 2010

In Brief

A Phase 3 clinical trial evaluating Cultivated conjunctival transplantation for Pterygium and 3 related conditions. Completed, enrolled 80 participants across 1 site.

Detailed Summary

To evaluate the use of cultivated conjunctival epithelial equivalents for the treatment of ocular diseases

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPterygium, Ocular Surface Disease, Stevens Johnson Syndrome, Chemical Injury
CountriesSingapore
CollaboratorsInternational Stem Cell Forum, National Medical Research Council (NMRC), Singapore, Singapore Eye Research Institute

Timeline

Phase 3CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 30, 2006
Enrollment StartOct 1, 2001
Study CompletionDec 1, 2003
TodayJul 2, 2026
Posted 20.0 years ago

Interventions

Cultivated conjunctival transplantationprocedure